The goal of this clinical trial is to verify the efficacy and safety of pulsed electric field (PEF) treatment of early-stage unreseectable non-small cell lung cancer(NSCLC) patients.
The main questions it aims to answer are:
* Safety of PEF treatment of early-stage unreseectable NSCLC patients. * Locoregional control of ablated lesions. * Survival and quality of life assessment of early-stage unreseectable NSCLC patients.
None
The subject cannot tolerate or refuses general anesthesia;
Has a history of severe allergic reactions;
Has contraindications to bronchoscopy or refuses bronchoscopy;